Compare Mirae Asset Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹99
₹500
Expense Ratio
1.94
1.93
NAV
₹43.04
₹487.09
Fund Started
11 Jun 2018
04 Jun 1999
Fund Size
₹2753.72 Cr
₹4063.64 Cr
Exit Load
Exit load of 1% if redeemed within 1 year.
Exit load of 0.50% if redeemed within 15 days
1 Year
9.03%
7.57%
3 Year
22.30%
24.68%
5 Year
14.21%
15.62%
Equity
99.92%
98.16%
Cash
0.08%
1.77%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.20% |
Divi's Laboratories Ltd. | 7.93% |
Glenmark Pharmaceuticals Ltd. | 6.94% |
JB Chemicals & Pharmaceuticals Ltd. | 6.88% |
Apollo Hospitals Enterprise Ltd. | 6.15% |
Lupin Ltd. | 5.06% |
Aurobindo Pharma Ltd. | 4.32% |
Dr. Reddy's Laboratories Ltd. | 4.31% |
Fortis Healthcare Ltd. | 3.73% |
Laurus Labs Ltd. | 3.56% |
Sun Pharmaceutical Industries Ltd. | 12.11% |
Divi's Laboratories Ltd. | 6.59% |
Acutaas Chemicals Ltd. | 5.67% |
Apollo Hospitals Enterprise Ltd. | 5.48% |
Max Healthcare Institute Ltd. | 4.97% |
Lupin Ltd. | 4.10% |
Aster DM Healthcare Ltd. | 3.96% |
Torrent Pharmaceuticals Ltd. | 3.74% |
Aether Industries Ltd. | 3.56% |
Biocon Ltd. | 3.33% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
11 Jun 2018
04 Jun 1999
